Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
User experiences vary dramatically with some reporting maintained benefits months after stopping while others notice gradual decline toward pre-treatment baseline, creating confusion about optimal usage patterns including continuous application versus cycling protocols
A total of 12 patients (29.3%) were thought to have received a durable response, while 29 patients (70.7%) received a non-durable response

Micha Karliski: nothing to disclose Poster Session II - DIGITAL TRANSFORMATION, AI AND ROBOTICS 07.00 - DIGITAL TRANSFORMATION, AI AND ROBOTICS - 07.01 - TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE P894 - ESOC25-982 ARTIFICIAL INTELLIGENCE-BASED SPATIO-TEMPORAL ANALYSIS FOR MODIFIED THROMBOLYSIS IN CEREBRAL INFARCTION SCORING Jichang Luo 1 , Botao Hou 2 , Wanying Liao 3 , Renjie Yang 4 , Tao Wang 4 , Xuesong Bai 4 , Jie Wang 4 , Haozhi Gong 4 , Tianhua Li 4 , Bin Yang 4 , Yu Zhang 2 , Liqun Jiao 4 , Xi Chen 2 1 Department of Neurosurgery, Xuanwu Hospital, Capital Medical University., Beijing, China, 2 State Key Laboratory of Industrial Control Technology, College of Control Science and Engineering, Zhejiang University, Hangzhou, China, Hangzhou, China, 3 Department of Gastroenterology, Peking Union Medical College Hospital (PUMCH), Beijing, China, 4 Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China, Beijing, China Background and Aims: Acute ischemic stroke (AIS) leads to significant global mortality and disability
